(Q79866587)
Statements
Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care (English)
M N Cook
C J Girman
P P Stein
28 February 2007